Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
17m
EU regulator backs use of Novo's Wegovy for obesity-related heart condition
This marks the regulator's second backing for a use of Wegovy beyond weight loss and further strengthens Novo's case that the ...
NJBIZ
48m
Novo Nordisk expects Ozempic in next round of Medicare price talks
In August 2023, the U.S. Department of Health and Human Services announced the first 10 drugs covered under Medicare Part D ...
Republic Business on MSN
36m
Obesity drug developer BioAge seeks up to $587 milllion valuation in US IPO
Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Makes MLB history
COVID, Wuhan market link
Rally attendees injured
Ban called for in TX schools
To get a second moon
Man charged for threats
Gun case sentencing delay
To receive Holbrooke award
NYC subway joyride arrest
Held in criminal contempt
30 yrs in prison for assault
Retires after 17 seasons
Statue damaged by vandal
US healthcare system falls
FTC on privacy controls
Hails economic progress
California deepfake ban
EU warns Apple
Sets new WNBA record
Dow, S&P hit record highs
AC mayor, wife indicted
160M euros to Ukraine
Israel strikes Hezbollah
Deal to build new arena
Los Angeles dengue cases
Existing home sales drop
Launches AI assistant
Opposes Israel arms sales
Retaliated against scientists
Cancer deaths decline
New SEC stock pricing rule
Toy Hall of Fame finalists
UN backs Palestine
Related topics
Ozempic
Novo Nordisk
Amycretin
Feedback